Diaceutics are finalists in the Data Analytics/Business Intelligence category at the Fierce Healthcare Innovation Awards 2021. The awards are organised by the publisher of Fierce Healthcare and will identify and showcase companies with outstanding innovation who are driving improvements and transforming the healthcare industry.
The expert panel of judges will determine which companies demonstrate innovative solutions that have the greatest potential to save money, engage patients, or revolutionize the industry. The winners will be announced in a special Innovation Report in December. Diaceutics’ entries focus on the application of machine learning and AI to identify the best possible testing journey for patients using DDPs® (Diagnostic Deductive Pathways) enabled by DXRX – The Diagnostic Network®. DXRX is the world’s first diagnostic commercialisation platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories
Commenting on the news, Sarah Colgan, Director of Global Marketing at Diaceutics said, “We are honoured to have been shortlisted in the Data Analytics/Business Intelligence category. Since launching our DXRX platform just 12 months ago, our ability to harmonize multiple global pipelines of complex diagnostic testing data into actionable commercial insights for our pharmaceutical customers has rapidly accelerated, which is great news for the industry and most importantly, for patients. We thank Fierce Healthcare for celebrating the value of our Deductive Diagnostic Pathways (DDPs®) in getting more patients access to the right treatment at the right time.”
Diaceutics has been shortlisted alongside Codoxo's Forensic AI Platform, Healthcare's Data Science Platform ClosedLoop and Hospital IQ Operations Management Platform.
Request a Demo now to find out more about DXRX – The Diagnostic Network® DXRX Data - Diaceutics
